Effect of an anticoagulant (heparin versus nafamostat mesilate) on the extrinsic coagulation pathway in chronic hemodialysis.
Matsuo
T
T
Matsuo
M
M
Kario
K
K
Koide
M
M
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000494:pharmacology* / Q000627:therapeutic use*; D001550:Benzamidines; D001779:Blood Coagulation Factors / Q000187:drug effects*; D005260:Female; D006146:Guanidines / Q000494:pharmacology* / Q000627:therapeutic use*; D006493:Heparin / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis
D000925:Anticoagulants; D001550:Benzamidines; D001779:Blood Coagulation Factors; D006146:Guanidines; D006493:Heparin; C032855:nafamostat